New clinical trial marks third study underway with neflamapimod in neurodegenerative disease

New results from the NURTURE study demonstrate that pre-symptomatic infants treated with SPINRAZA are achieving motor milestones that are unprecedented in the natural history of the disease, including 100 percent of children sitting without support and 88 percent walking independently

An article published in Experimental Biology and Medicine (Volume 244, Issue 9, June 2019) (https://journals.sagepub.com/doi/pdf/10.1177/1535370219843827) identifies a new target for the treatment of idiopathic pulmonary fibrosis.

Picovax® has been approved by the Danish Medicines Agency, and the WHO prequalification is expected by the end of 2019, enabling initial delivery of up to 100 million doses globally via UN agencies in 2020-2024

Pilot study published in Journal of Pediatric Urology

The Feinstein Institutes for Medical Research Professor Betty Diamond, MD, has published findings in the July issue of Nature Immunology that provide new insight into the immune cell landscape of the kidneys of patients with lupus.

Patient needs take center stage as the companies leverage their strengths in coordinated primary, specialty, and urgent care

Data are part of the DISCOVER 1 and 2 program, the first Phase 3 studies to evaluate a selective IL-23 p19 inhibitor in the treatment of psoriatic arthritis

Two posters to be presented at the 2019 annual congress of the European Hematology Association on 14th June

Alliance will create the largest digitally enabled clinical quality improvement and research network in the US

The partnership will enable state and local governments to decrease liability and privacy issues with cloudPWR's leading compliant registry solution and set a new standard for tracking and tracing medical and legalized cannabis

Request for proposals issued for innovative approaches for improving provider performance and enhancing patient care and outcomes in unresectable stage III and IV non-small cell lung cancer.

CancerCare® has announced the publication of a patient manifesto, declaring the fundamental importance of including patients' values and priorities in cancer treatment planning.

B dot Medical Inc. issued the following announcement on May 24.Original source can be found here.

IBE President Dr. Martin Brodie Receives Epilepsy Lifetime Accelerator Award at AEDD

Five PLEDGE studies now active and enrolling patients to evaluate the safety and efficacy of relamorelin (investigational drug) in people with diabetic gastroparesis

Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital will hold its annual Minds Matter Benefit Dinner on Friday, May 17 at 6 p.m. for an evening to honor and support individuals affected by brain and spinal tumors. This year's theme is "Darkness to Light" and includes iconic Chicago television news anchor Robin Robinson who will serve as the master of ceremonies for the black-tie benefit dinner.

Eisai Inc. presented the latest clinical results on FYCOMPA®(perampanel) CIII, at the 2019 American Academy of Neurology Annual Meeting in Philadelphia, including analyses highlighting the health and economic benefits of FYCOMPA.

Newly identified subsets of cell types present in joint tissue in people with rheumatoid arthritis and how they interact may explain why only some people respond to existing medications, according to two studies by co-senior author Laura Donlin, PhD, Co-Director of the Derfner Foundation Precision Medicine Laboratory at Hospital for Special Surgery (HSS) and collaborating colleagues.

This week, the House of Representatives will vote on Rep. Ann Kuster’s (D-N.H.) Protecting Americans with Preexisting Conditions Act (HR 986).